Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 137.70
-1.70 (-1.22%)
At close: Jan 28, 2026
Ipsen Market Cap
Ipsen has a market cap or net worth of €11.44 billion as of January 28, 2026. Its market cap has increased by 12.06% in one year.
Market Cap
11.44B
Enterprise Value
10.96B
Revenue
3.76B
Ranking
n/a
PE Ratio
25.95
Stock Price
€137.70
Market Cap Chart
Since December 7, 2005, Ipsen's market cap has increased from 1.78B to 11.44B, an increase of 544.41%. That is a compound annual growth rate of 9.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 11.44B | 17.14% |
| Dec 31, 2025 | 9.77B | 6.72% |
| Dec 31, 2024 | 9.15B | 2.72% |
| Dec 29, 2023 | 8.91B | 7.65% |
| Dec 30, 2022 | 8.28B | 25.05% |
| Dec 31, 2021 | 6.62B | 18.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 122.79B |
| Sanofi | 95.87B |
| Sartorius Stedim Biotech | 20.04B |
| Eurofins Scientific SE | 12.49B |
| bioMérieux | 12.24B |
| ABIVAX Société Anonyme | 8.30B |
| Virbac | 3.05B |
| emeis Société anonyme | 2.21B |